FDA Orange Book
Generic for Triostat
Triostat contains liothyronine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Triostat is liothyronine. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book.
Run it in Rivvi
Map Triostat and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Triostat products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| injectable, injection | EQ 0.01MG BASE/ML | Discontinued | None | 1 | None |
NDA 020105, held by PH HEALTH LTD. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic liothyronine
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| XGEN PHARMACEUTICALS DJB INC | 076923 | None (No TE code listed) | August 17, 2005 | EQ 0.01MG BASE/ML |
Questions
Is there a generic for Triostat?
Yes. The generic name for Triostat is liothyronine. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book.
What is the generic name for Triostat?
The active ingredient in Triostat is liothyronine, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.